Jerusalem Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Stock Rating
0
Price Target
0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
0
Downside
-100.00%
Analysts
0
Price Target
0.00
-
Jerusalem Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
Jerusalem Pharmaceuticals's Price has increased by 100.00% In the last year, going from 0.00 to 0.00. In the next year, analysts expect Fair Value to reach 0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
2025 Fair Value Forecast
0.00
2026 Fair Value Forecast
0.00
2027 Fair Value Forecast
0.00
2028 Fair Value Forecast
0.00
2029 Fair Value Forecast
0.00
2030 Fair Value Forecast
0.00
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$745.95 | Buy/Sell | $636.99 | 12.27% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$145.74 | Buy/Sell | $174.55 | 16.65% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$125.23 | Buy/Sell | $130.51 | 11.00% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£109.14 | Buy/Sell | £165.99 | 48.27% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.39 | Buy/Sell | $32.87 | 20.13% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$393.48 | Buy/Sell | $457.59 | 14.36% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.30 | Buy/Sell | $58.15 | 13.87% |
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$893.99 | Buy/Sell | $961.26 | 17.45% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSK Stock Forecast | GSK | Outperform |
12
|
£15.84 | Buy/Sell | £17.30 | 23.11% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$153.11 | Buy/Sell | $220.47 | 44.67% |
| MRK Stock Forecast | Merck KGaA | Outperform |
18
|
146.75€ | Buy/Sell | 190.06€ | 24.70% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AGN Stock Forecast | Allergan | - |
0
|
$47.83 | Buy/Sell | $193.25 | -100.00% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$39.65 | Buy/Sell | $44.86 | 13.49% |
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$145.16 | Buy/Sell | $245.24 | 48.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.12 | Buy/Sell | $11.73 | 7.91% |
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$236.93 | Buy/Sell | $284.08 | 25.35% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.80 | Buy/Sell | $49.29 | 13.80% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IPN Stock Forecast | Ipsen | Outperform |
17
|
106.30€ | Buy/Sell | 127.95€ | 10.07% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$67.00 | Buy/Sell | $87.92 | 40.30% |
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$40.81 | Buy/Sell | $55.60 | 47.51% |
Jerusalem Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
Jerusalem Pharmaceuticals's EPS has increased by 100.00% In the last year, going from 0.00 to 0.00. In the next year, analysts expect EPS to reach 0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
2025 EPS Forecast
0.00
2026 EPS Forecast
0.00
2027 EPS Forecast
0.00
2028 EPS Forecast
0.00
2029 EPS Forecast
0.00
2030 EPS Forecast
0.00
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£17.89 | Buy/Sell | £28.11 | 65.34% |
| DPH Stock Forecast | Dechra Pharmaceuticals PLC | - |
18
|
£38.66 | Buy/Sell | £39.86 | -100.00% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$143.12 | Buy/Sell | $145.00 | 13.89% |
Site Navigation
.jpg)